Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis

Human papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors like regional variability, HPV genotype, the population studied, HPV vaccination status, and anatomical sample collection location influencing the prevalence and pathology of HPV-induced cancer. HPV-16 and -1...

Full description

Bibliographic Details
Main Authors: Meenu Jain, Dhananjay Yadav, Urmila Jarouliya, Vishal Chavda, Arun Kumar Yadav, Bipin Chaurasia, Minseok Song
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/12/12/1380
_version_ 1827573836087820288
author Meenu Jain
Dhananjay Yadav
Urmila Jarouliya
Vishal Chavda
Arun Kumar Yadav
Bipin Chaurasia
Minseok Song
author_facet Meenu Jain
Dhananjay Yadav
Urmila Jarouliya
Vishal Chavda
Arun Kumar Yadav
Bipin Chaurasia
Minseok Song
author_sort Meenu Jain
collection DOAJ
description Human papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors like regional variability, HPV genotype, the population studied, HPV vaccination status, and anatomical sample collection location influencing the prevalence and pathology of HPV-induced cancer. HPV-16 and -18 are mainly responsible for the progression of several cancers, including cervix, anus, vagina, penis, vulva, and oropharynx. The oncogenic ability of HPV is not only sufficient for the progression of malignancy, but also for other tumor-generating steps required for the production of invasive cancer, such as coinfection with other viruses, lifestyle factors such as high parity, smoking, tobacco chewing, use of contraceptives for a long time, and immune responses such as stimulation of chronic stromal inflammation and immune deviation in the tumor microenvironment. Viral evasion from immunosurveillance also supports viral persistence, and virus-like particle-based prophylactic vaccines have been licensed, which are effective against high-risk HPV types. In addition, vaccination awareness programs and preventive strategies could help reduce the rate and incidence of HPV infection. In this review, we emphasize HPV infection and its role in cancer progression, molecular and immunopathogenesis, host immune response, immune evasion by HPV, vaccination, and preventive schemes battling HPV infection and HPV-related cancers.
first_indexed 2024-03-08T20:27:50Z
format Article
id doaj.art-3f130b7519784e0b90c9b92040a4b3ef
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-08T20:27:50Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-3f130b7519784e0b90c9b92040a4b3ef2023-12-22T14:30:45ZengMDPI AGPathogens2076-08172023-11-011212138010.3390/pathogens12121380Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated CarcinogenesisMeenu Jain0Dhananjay Yadav1Urmila Jarouliya2Vishal Chavda3Arun Kumar Yadav4Bipin Chaurasia5Minseok Song6Department of Microbiology, Viral Research and Diagnostic Laboratory, Gajra Raja Medical College, Gwalior 474009, Madhya Pradesh, IndiaDepartment of Life Science, Yeungnam University, Gyeongsan 38541, Republic of KoreaSOS in Biochemistry, Jiwaji University, Gwalior 474011 Madhya Pradesh, IndiaDepartment of Pathology, Stanford School of Medicine, Stanford University Medical Center, Palo Alto, CA 94305, USADepartment of Microbiology, Guru Gobind Singh Medical College and Hospital, Baba Farid University of Health Sciences, Faridkot 151203, Punjab, IndiaDepartment of Neurosurgery, Neurosurgery Clinic, Birgunj 44300, NepalDepartment of Life Science, Yeungnam University, Gyeongsan 38541, Republic of KoreaHuman papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors like regional variability, HPV genotype, the population studied, HPV vaccination status, and anatomical sample collection location influencing the prevalence and pathology of HPV-induced cancer. HPV-16 and -18 are mainly responsible for the progression of several cancers, including cervix, anus, vagina, penis, vulva, and oropharynx. The oncogenic ability of HPV is not only sufficient for the progression of malignancy, but also for other tumor-generating steps required for the production of invasive cancer, such as coinfection with other viruses, lifestyle factors such as high parity, smoking, tobacco chewing, use of contraceptives for a long time, and immune responses such as stimulation of chronic stromal inflammation and immune deviation in the tumor microenvironment. Viral evasion from immunosurveillance also supports viral persistence, and virus-like particle-based prophylactic vaccines have been licensed, which are effective against high-risk HPV types. In addition, vaccination awareness programs and preventive strategies could help reduce the rate and incidence of HPV infection. In this review, we emphasize HPV infection and its role in cancer progression, molecular and immunopathogenesis, host immune response, immune evasion by HPV, vaccination, and preventive schemes battling HPV infection and HPV-related cancers.https://www.mdpi.com/2076-0817/12/12/1380HPV-infectionHPV-associated carcinogenesisimmuno-pathogenesisimmune evasionvaccination
spellingShingle Meenu Jain
Dhananjay Yadav
Urmila Jarouliya
Vishal Chavda
Arun Kumar Yadav
Bipin Chaurasia
Minseok Song
Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
Pathogens
HPV-infection
HPV-associated carcinogenesis
immuno-pathogenesis
immune evasion
vaccination
title Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
title_full Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
title_fullStr Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
title_full_unstemmed Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
title_short Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis
title_sort epidemiology molecular pathogenesis immuno pathogenesis immune escape mechanisms and vaccine evaluation for hpv associated carcinogenesis
topic HPV-infection
HPV-associated carcinogenesis
immuno-pathogenesis
immune evasion
vaccination
url https://www.mdpi.com/2076-0817/12/12/1380
work_keys_str_mv AT meenujain epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis
AT dhananjayyadav epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis
AT urmilajarouliya epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis
AT vishalchavda epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis
AT arunkumaryadav epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis
AT bipinchaurasia epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis
AT minseoksong epidemiologymolecularpathogenesisimmunopathogenesisimmuneescapemechanismsandvaccineevaluationforhpvassociatedcarcinogenesis